Dr Anne Wheeler Giuliano, MD - Medicare Interventional Radiology in Billings, MT

Dr Anne Wheeler Giuliano, MD is a medicare enrolled "Radiology - Vascular & Interventional Radiology" physician in Billings, Montana. She went to University Of Massachusetts Medical School and graduated in 1993 and has 31 years of diverse experience with area of expertise as Interventional Radiology. She is a member of the group practice Imaging Group Of Delaware Pa, Radiology Associates Of Southwest Louisiana, Imaging Associates Of Indiana Pc, Radiology Affiliates Of Central New Jersey P C, Louisville Radiology Imaging Consultants Pllc, Empire State Radiology P C, Northside Radiology Associates Llc, Coastal Radiology Associates Pllc, Greensboro Radiology Pa, Mori Bean And Brooks Inc, Imaging Associates Of Michigan Pllc and her current practice location is 3307 Grand Ave, Suite 201, Billings, Montana. You can reach out to her office (for appointments etc.) via phone at (406) 969-5194.

Dr Anne Wheeler Giuliano is licensed to practice in Montana (license number 8562) and she also participates in the medicare program. She may accept medicare assignments (which means she may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance) and her NPI Number is 1811938590.

Contact Information

Dr Anne Wheeler Giuliano, MD
3307 Grand Ave, Suite 201,
Billings, MT 59102-6546
(406) 969-5194
(406) 969-5195



Physician's Profile

Full NameDr Anne Wheeler Giuliano
GenderFemale
SpecialityInterventional Radiology
Experience31 Years
Location3307 Grand Ave, Billings, Montana
Accepts Medicare AssignmentsMay be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Anne Wheeler Giuliano attended and graduated from University Of Massachusetts Medical School in 1993
  NPI Data:
  • NPI Number: 1811938590
  • Provider Enumeration Date: 06/10/2006
  • Last Update Date: 06/15/2017
  Medicare PECOS Information:
  • PECOS PAC ID: 2365489754
  • Enrollment ID: I20051017000653

Medical Identifiers

Medical identifiers for Dr Anne Wheeler Giuliano such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1811938590NPI-NPPES
114293300MedicaidWY
14688MedicaidMT
18031OtherMTBLUE CROSS BLUE SHIELD

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2085R0202XRadiology - Diagnostic Radiology 8562 (Montana)Secondary
2085R0204XRadiology - Vascular & Interventional Radiology 8562 (Montana)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Holy Redeemer Hospital And Medical CenterMeadowbrook, PAHospital
Bayfront Health Port CharlottePort charlotte, FLHospital
Robert Wood Johnson University Hospital At HamiltonHamilton, NJHospital
Regional Hospital Of ScrantonScranton, PAHospital
St Francis Hospital - The Heart CenterRoslyn, NYHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Imaging Group Of Delaware Pa054715247233
Radiology Associates Of Southwest Louisiana094124356294
Imaging Associates Of Indiana Pc1254503345202
Radiology Affiliates Of Central New Jersey P C175927723964
Louisville Radiology Imaging Consultants Pllc226443612054
Empire State Radiology P C4385075241175
Northside Radiology Associates Llc4486555398213
Coastal Radiology Associates Pllc822400269688
Greensboro Radiology Pa8729074901207
Mori Bean And Brooks Inc8820077878633
Imaging Associates Of Michigan Pllc953743438666

News Archive

Retiring later is unlikely to affect men's quality of life

Raising the retirement age to increase financial stability does not make men worse off psychologically in the long-run, according to a new study by Dr. Elizabeth Mokyr Horner, from the University of California, Berkeley in the US. Her work shows that individuals go through the same psychological stages as they adjust to retirement, with life satisfaction stabilizing after 70, irrespective of how old they are when they retire.

Nu Skin Enterprises declares quarterly cash dividend of $0.125 per share

Nu Skin Enterprises, Inc. today announced that its board of directors declared a 9 percent increase in the quarterly cash dividend to $0.125 per share. Annually, this would increase the dividend to $0.50, up from $0.46 in the prior year. The increase begins in the first quarter and will be paid on March 17, 2010, to shareholders of record on Feb. 26, 2010.

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics, Inc.

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Anne Wheeler Giuliano allows following entities to bill medicare on her behalf.
Entity NameCoastal Radiology Associates Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1144270307
PECOS PAC ID: 8224002696
Enrollment ID: O20171004001190

News Archive

Retiring later is unlikely to affect men's quality of life

Raising the retirement age to increase financial stability does not make men worse off psychologically in the long-run, according to a new study by Dr. Elizabeth Mokyr Horner, from the University of California, Berkeley in the US. Her work shows that individuals go through the same psychological stages as they adjust to retirement, with life satisfaction stabilizing after 70, irrespective of how old they are when they retire.

Nu Skin Enterprises declares quarterly cash dividend of $0.125 per share

Nu Skin Enterprises, Inc. today announced that its board of directors declared a 9 percent increase in the quarterly cash dividend to $0.125 per share. Annually, this would increase the dividend to $0.50, up from $0.46 in the prior year. The increase begins in the first quarter and will be paid on March 17, 2010, to shareholders of record on Feb. 26, 2010.

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics, Inc.

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

Read more Medical News

› Verified 3 days ago

Entity NameEagle Partners Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1548450976
PECOS PAC ID: 9032205752
Enrollment ID: O20171026003386

News Archive

Retiring later is unlikely to affect men's quality of life

Raising the retirement age to increase financial stability does not make men worse off psychologically in the long-run, according to a new study by Dr. Elizabeth Mokyr Horner, from the University of California, Berkeley in the US. Her work shows that individuals go through the same psychological stages as they adjust to retirement, with life satisfaction stabilizing after 70, irrespective of how old they are when they retire.

Nu Skin Enterprises declares quarterly cash dividend of $0.125 per share

Nu Skin Enterprises, Inc. today announced that its board of directors declared a 9 percent increase in the quarterly cash dividend to $0.125 per share. Annually, this would increase the dividend to $0.50, up from $0.46 in the prior year. The increase begins in the first quarter and will be paid on March 17, 2010, to shareholders of record on Feb. 26, 2010.

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics, Inc.

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

Read more Medical News

› Verified 3 days ago

Entity NameImaging Associates Of New Mexico Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1629592464
PECOS PAC ID: 4981970233
Enrollment ID: O20180214001644

News Archive

Retiring later is unlikely to affect men's quality of life

Raising the retirement age to increase financial stability does not make men worse off psychologically in the long-run, according to a new study by Dr. Elizabeth Mokyr Horner, from the University of California, Berkeley in the US. Her work shows that individuals go through the same psychological stages as they adjust to retirement, with life satisfaction stabilizing after 70, irrespective of how old they are when they retire.

Nu Skin Enterprises declares quarterly cash dividend of $0.125 per share

Nu Skin Enterprises, Inc. today announced that its board of directors declared a 9 percent increase in the quarterly cash dividend to $0.125 per share. Annually, this would increase the dividend to $0.50, up from $0.46 in the prior year. The increase begins in the first quarter and will be paid on March 17, 2010, to shareholders of record on Feb. 26, 2010.

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics, Inc.

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

Read more Medical News

› Verified 3 days ago

Entity NameImaging Associates Of Michigan Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1164943007
PECOS PAC ID: 9537434386
Enrollment ID: O20180411002226

News Archive

Retiring later is unlikely to affect men's quality of life

Raising the retirement age to increase financial stability does not make men worse off psychologically in the long-run, according to a new study by Dr. Elizabeth Mokyr Horner, from the University of California, Berkeley in the US. Her work shows that individuals go through the same psychological stages as they adjust to retirement, with life satisfaction stabilizing after 70, irrespective of how old they are when they retire.

Nu Skin Enterprises declares quarterly cash dividend of $0.125 per share

Nu Skin Enterprises, Inc. today announced that its board of directors declared a 9 percent increase in the quarterly cash dividend to $0.125 per share. Annually, this would increase the dividend to $0.50, up from $0.46 in the prior year. The increase begins in the first quarter and will be paid on March 17, 2010, to shareholders of record on Feb. 26, 2010.

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics, Inc.

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

Read more Medical News

› Verified 3 days ago

Entity NameSingleton Associates Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1538107875
PECOS PAC ID: 6305731118
Enrollment ID: O20180629002468

News Archive

Retiring later is unlikely to affect men's quality of life

Raising the retirement age to increase financial stability does not make men worse off psychologically in the long-run, according to a new study by Dr. Elizabeth Mokyr Horner, from the University of California, Berkeley in the US. Her work shows that individuals go through the same psychological stages as they adjust to retirement, with life satisfaction stabilizing after 70, irrespective of how old they are when they retire.

Nu Skin Enterprises declares quarterly cash dividend of $0.125 per share

Nu Skin Enterprises, Inc. today announced that its board of directors declared a 9 percent increase in the quarterly cash dividend to $0.125 per share. Annually, this would increase the dividend to $0.50, up from $0.46 in the prior year. The increase begins in the first quarter and will be paid on March 17, 2010, to shareholders of record on Feb. 26, 2010.

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics, Inc.

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

Read more Medical News

› Verified 3 days ago

Entity NameSouthwest Diagnostic Imaging Ltd
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1902896236
PECOS PAC ID: 7416946199
Enrollment ID: O20190213002793

News Archive

Retiring later is unlikely to affect men's quality of life

Raising the retirement age to increase financial stability does not make men worse off psychologically in the long-run, according to a new study by Dr. Elizabeth Mokyr Horner, from the University of California, Berkeley in the US. Her work shows that individuals go through the same psychological stages as they adjust to retirement, with life satisfaction stabilizing after 70, irrespective of how old they are when they retire.

Nu Skin Enterprises declares quarterly cash dividend of $0.125 per share

Nu Skin Enterprises, Inc. today announced that its board of directors declared a 9 percent increase in the quarterly cash dividend to $0.125 per share. Annually, this would increase the dividend to $0.50, up from $0.46 in the prior year. The increase begins in the first quarter and will be paid on March 17, 2010, to shareholders of record on Feb. 26, 2010.

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics, Inc.

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

Read more Medical News

› Verified 3 days ago

Entity NameEllis Bandt Birkin Kollins & Wong Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1578584678
PECOS PAC ID: 4486568946
Enrollment ID: O20190227001250

News Archive

Retiring later is unlikely to affect men's quality of life

Raising the retirement age to increase financial stability does not make men worse off psychologically in the long-run, according to a new study by Dr. Elizabeth Mokyr Horner, from the University of California, Berkeley in the US. Her work shows that individuals go through the same psychological stages as they adjust to retirement, with life satisfaction stabilizing after 70, irrespective of how old they are when they retire.

Nu Skin Enterprises declares quarterly cash dividend of $0.125 per share

Nu Skin Enterprises, Inc. today announced that its board of directors declared a 9 percent increase in the quarterly cash dividend to $0.125 per share. Annually, this would increase the dividend to $0.50, up from $0.46 in the prior year. The increase begins in the first quarter and will be paid on March 17, 2010, to shareholders of record on Feb. 26, 2010.

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics, Inc.

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

Read more Medical News

› Verified 3 days ago

Entity NameImaging Associates Of Indiana Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1699072611
PECOS PAC ID: 1254503345
Enrollment ID: O20190822001434

News Archive

Retiring later is unlikely to affect men's quality of life

Raising the retirement age to increase financial stability does not make men worse off psychologically in the long-run, according to a new study by Dr. Elizabeth Mokyr Horner, from the University of California, Berkeley in the US. Her work shows that individuals go through the same psychological stages as they adjust to retirement, with life satisfaction stabilizing after 70, irrespective of how old they are when they retire.

Nu Skin Enterprises declares quarterly cash dividend of $0.125 per share

Nu Skin Enterprises, Inc. today announced that its board of directors declared a 9 percent increase in the quarterly cash dividend to $0.125 per share. Annually, this would increase the dividend to $0.50, up from $0.46 in the prior year. The increase begins in the first quarter and will be paid on March 17, 2010, to shareholders of record on Feb. 26, 2010.

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics, Inc.

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

Read more Medical News

› Verified 3 days ago

Entity NameRadiology Associates Of Southwest Louisiana
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1033215710
PECOS PAC ID: 0941243562
Enrollment ID: O20190913001832

News Archive

Retiring later is unlikely to affect men's quality of life

Raising the retirement age to increase financial stability does not make men worse off psychologically in the long-run, according to a new study by Dr. Elizabeth Mokyr Horner, from the University of California, Berkeley in the US. Her work shows that individuals go through the same psychological stages as they adjust to retirement, with life satisfaction stabilizing after 70, irrespective of how old they are when they retire.

Nu Skin Enterprises declares quarterly cash dividend of $0.125 per share

Nu Skin Enterprises, Inc. today announced that its board of directors declared a 9 percent increase in the quarterly cash dividend to $0.125 per share. Annually, this would increase the dividend to $0.50, up from $0.46 in the prior year. The increase begins in the first quarter and will be paid on March 17, 2010, to shareholders of record on Feb. 26, 2010.

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics, Inc.

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

Read more Medical News

› Verified 3 days ago

Entity NameColumbus Radiology Corp
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1669408159
PECOS PAC ID: 6507754983
Enrollment ID: O20190925001016

News Archive

Retiring later is unlikely to affect men's quality of life

Raising the retirement age to increase financial stability does not make men worse off psychologically in the long-run, according to a new study by Dr. Elizabeth Mokyr Horner, from the University of California, Berkeley in the US. Her work shows that individuals go through the same psychological stages as they adjust to retirement, with life satisfaction stabilizing after 70, irrespective of how old they are when they retire.

Nu Skin Enterprises declares quarterly cash dividend of $0.125 per share

Nu Skin Enterprises, Inc. today announced that its board of directors declared a 9 percent increase in the quarterly cash dividend to $0.125 per share. Annually, this would increase the dividend to $0.50, up from $0.46 in the prior year. The increase begins in the first quarter and will be paid on March 17, 2010, to shareholders of record on Feb. 26, 2010.

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics, Inc.

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

Read more Medical News

› Verified 3 days ago

Entity NameRadiology Affiliates Of Central New Jersey P C
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1811994791
PECOS PAC ID: 1759277239
Enrollment ID: O20191031001892

News Archive

Retiring later is unlikely to affect men's quality of life

Raising the retirement age to increase financial stability does not make men worse off psychologically in the long-run, according to a new study by Dr. Elizabeth Mokyr Horner, from the University of California, Berkeley in the US. Her work shows that individuals go through the same psychological stages as they adjust to retirement, with life satisfaction stabilizing after 70, irrespective of how old they are when they retire.

Nu Skin Enterprises declares quarterly cash dividend of $0.125 per share

Nu Skin Enterprises, Inc. today announced that its board of directors declared a 9 percent increase in the quarterly cash dividend to $0.125 per share. Annually, this would increase the dividend to $0.50, up from $0.46 in the prior year. The increase begins in the first quarter and will be paid on March 17, 2010, to shareholders of record on Feb. 26, 2010.

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics, Inc.

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

Read more Medical News

› Verified 3 days ago

Entity NameLouisville Radiology Imaging Consultants Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1639115447
PECOS PAC ID: 2264436120
Enrollment ID: O20200313000417

News Archive

Retiring later is unlikely to affect men's quality of life

Raising the retirement age to increase financial stability does not make men worse off psychologically in the long-run, according to a new study by Dr. Elizabeth Mokyr Horner, from the University of California, Berkeley in the US. Her work shows that individuals go through the same psychological stages as they adjust to retirement, with life satisfaction stabilizing after 70, irrespective of how old they are when they retire.

Nu Skin Enterprises declares quarterly cash dividend of $0.125 per share

Nu Skin Enterprises, Inc. today announced that its board of directors declared a 9 percent increase in the quarterly cash dividend to $0.125 per share. Annually, this would increase the dividend to $0.50, up from $0.46 in the prior year. The increase begins in the first quarter and will be paid on March 17, 2010, to shareholders of record on Feb. 26, 2010.

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics, Inc.

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

Read more Medical News

› Verified 3 days ago

Entity NameMori Bean And Brooks Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1093782070
PECOS PAC ID: 8820077878
Enrollment ID: O20200609000704

News Archive

Retiring later is unlikely to affect men's quality of life

Raising the retirement age to increase financial stability does not make men worse off psychologically in the long-run, according to a new study by Dr. Elizabeth Mokyr Horner, from the University of California, Berkeley in the US. Her work shows that individuals go through the same psychological stages as they adjust to retirement, with life satisfaction stabilizing after 70, irrespective of how old they are when they retire.

Nu Skin Enterprises declares quarterly cash dividend of $0.125 per share

Nu Skin Enterprises, Inc. today announced that its board of directors declared a 9 percent increase in the quarterly cash dividend to $0.125 per share. Annually, this would increase the dividend to $0.50, up from $0.46 in the prior year. The increase begins in the first quarter and will be paid on March 17, 2010, to shareholders of record on Feb. 26, 2010.

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics, Inc.

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

Read more Medical News

› Verified 3 days ago

Entity NameGreensboro Radiology Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1821035999
PECOS PAC ID: 8729074901
Enrollment ID: O20200817002305

News Archive

Retiring later is unlikely to affect men's quality of life

Raising the retirement age to increase financial stability does not make men worse off psychologically in the long-run, according to a new study by Dr. Elizabeth Mokyr Horner, from the University of California, Berkeley in the US. Her work shows that individuals go through the same psychological stages as they adjust to retirement, with life satisfaction stabilizing after 70, irrespective of how old they are when they retire.

Nu Skin Enterprises declares quarterly cash dividend of $0.125 per share

Nu Skin Enterprises, Inc. today announced that its board of directors declared a 9 percent increase in the quarterly cash dividend to $0.125 per share. Annually, this would increase the dividend to $0.50, up from $0.46 in the prior year. The increase begins in the first quarter and will be paid on March 17, 2010, to shareholders of record on Feb. 26, 2010.

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics, Inc.

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

Read more Medical News

› Verified 3 days ago

Entity NameEmpire State Radiology P C
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1255962783
PECOS PAC ID: 4385075241
Enrollment ID: O20200825003531

News Archive

Retiring later is unlikely to affect men's quality of life

Raising the retirement age to increase financial stability does not make men worse off psychologically in the long-run, according to a new study by Dr. Elizabeth Mokyr Horner, from the University of California, Berkeley in the US. Her work shows that individuals go through the same psychological stages as they adjust to retirement, with life satisfaction stabilizing after 70, irrespective of how old they are when they retire.

Nu Skin Enterprises declares quarterly cash dividend of $0.125 per share

Nu Skin Enterprises, Inc. today announced that its board of directors declared a 9 percent increase in the quarterly cash dividend to $0.125 per share. Annually, this would increase the dividend to $0.50, up from $0.46 in the prior year. The increase begins in the first quarter and will be paid on March 17, 2010, to shareholders of record on Feb. 26, 2010.

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics, Inc.

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

Read more Medical News

› Verified 3 days ago

Entity NameNorthside Radiology Associates Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1013960657
PECOS PAC ID: 4486555398
Enrollment ID: O20200831003044

News Archive

Retiring later is unlikely to affect men's quality of life

Raising the retirement age to increase financial stability does not make men worse off psychologically in the long-run, according to a new study by Dr. Elizabeth Mokyr Horner, from the University of California, Berkeley in the US. Her work shows that individuals go through the same psychological stages as they adjust to retirement, with life satisfaction stabilizing after 70, irrespective of how old they are when they retire.

Nu Skin Enterprises declares quarterly cash dividend of $0.125 per share

Nu Skin Enterprises, Inc. today announced that its board of directors declared a 9 percent increase in the quarterly cash dividend to $0.125 per share. Annually, this would increase the dividend to $0.50, up from $0.46 in the prior year. The increase begins in the first quarter and will be paid on March 17, 2010, to shareholders of record on Feb. 26, 2010.

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics, Inc.

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

Read more Medical News

› Verified 3 days ago

Entity NameGolden State Imaging Associates Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1144872052
PECOS PAC ID: 1254761315
Enrollment ID: O20200916002356

News Archive

Retiring later is unlikely to affect men's quality of life

Raising the retirement age to increase financial stability does not make men worse off psychologically in the long-run, according to a new study by Dr. Elizabeth Mokyr Horner, from the University of California, Berkeley in the US. Her work shows that individuals go through the same psychological stages as they adjust to retirement, with life satisfaction stabilizing after 70, irrespective of how old they are when they retire.

Nu Skin Enterprises declares quarterly cash dividend of $0.125 per share

Nu Skin Enterprises, Inc. today announced that its board of directors declared a 9 percent increase in the quarterly cash dividend to $0.125 per share. Annually, this would increase the dividend to $0.50, up from $0.46 in the prior year. The increase begins in the first quarter and will be paid on March 17, 2010, to shareholders of record on Feb. 26, 2010.

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics, Inc.

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

Read more Medical News

› Verified 3 days ago

Entity NameSonoran Radiology Ltd
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1033745708
PECOS PAC ID: 3375964505
Enrollment ID: O20201019003197

News Archive

Retiring later is unlikely to affect men's quality of life

Raising the retirement age to increase financial stability does not make men worse off psychologically in the long-run, according to a new study by Dr. Elizabeth Mokyr Horner, from the University of California, Berkeley in the US. Her work shows that individuals go through the same psychological stages as they adjust to retirement, with life satisfaction stabilizing after 70, irrespective of how old they are when they retire.

Nu Skin Enterprises declares quarterly cash dividend of $0.125 per share

Nu Skin Enterprises, Inc. today announced that its board of directors declared a 9 percent increase in the quarterly cash dividend to $0.125 per share. Annually, this would increase the dividend to $0.50, up from $0.46 in the prior year. The increase begins in the first quarter and will be paid on March 17, 2010, to shareholders of record on Feb. 26, 2010.

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics, Inc.

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

Read more Medical News

› Verified 3 days ago

Entity NameImaging Group Of Delaware Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1164421574
PECOS PAC ID: 0547152472
Enrollment ID: O20220125003067

News Archive

Retiring later is unlikely to affect men's quality of life

Raising the retirement age to increase financial stability does not make men worse off psychologically in the long-run, according to a new study by Dr. Elizabeth Mokyr Horner, from the University of California, Berkeley in the US. Her work shows that individuals go through the same psychological stages as they adjust to retirement, with life satisfaction stabilizing after 70, irrespective of how old they are when they retire.

Nu Skin Enterprises declares quarterly cash dividend of $0.125 per share

Nu Skin Enterprises, Inc. today announced that its board of directors declared a 9 percent increase in the quarterly cash dividend to $0.125 per share. Annually, this would increase the dividend to $0.50, up from $0.46 in the prior year. The increase begins in the first quarter and will be paid on March 17, 2010, to shareholders of record on Feb. 26, 2010.

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics, Inc.

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Anne Wheeler Giuliano is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Anne Wheeler Giuliano, MD
2265 E Sunnyside Rd,
Idaho Falls, ID 83404-7598

Ph: (208) 552-8761
Dr Anne Wheeler Giuliano, MD
3307 Grand Ave, Suite 201,
Billings, MT 59102-6546

Ph: (406) 969-5194

News Archive

Retiring later is unlikely to affect men's quality of life

Raising the retirement age to increase financial stability does not make men worse off psychologically in the long-run, according to a new study by Dr. Elizabeth Mokyr Horner, from the University of California, Berkeley in the US. Her work shows that individuals go through the same psychological stages as they adjust to retirement, with life satisfaction stabilizing after 70, irrespective of how old they are when they retire.

Nu Skin Enterprises declares quarterly cash dividend of $0.125 per share

Nu Skin Enterprises, Inc. today announced that its board of directors declared a 9 percent increase in the quarterly cash dividend to $0.125 per share. Annually, this would increase the dividend to $0.50, up from $0.46 in the prior year. The increase begins in the first quarter and will be paid on March 17, 2010, to shareholders of record on Feb. 26, 2010.

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics, Inc.

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

Read more News

› Verified 3 days ago


Radiology Doctors in Billings, MT

Dr. Heather I Gale, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 2800 10th Ave N, Billings, MT 59101
Phone: 406-238-5046    Fax: 406-247-6053
Rebecca Susan Tarlton, MD
Radiology
Medicare: Medicare Enrolled
Practice Location: 1315 Golden Valley Cir, Billings, MT 59102
Phone: 406-238-6290    Fax: 406-238-6280
Dr. Brian Matthew Christenson, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 1233 N 30th St, Billings, MT 59101
Phone: 406-237-5491    Fax: 406-237-5499
Dr. Joseph Paul Dillard, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 2900 12th Ave N, Suite 210w, Billings, MT 59101
Phone: 406-237-5862    Fax: 406-238-6068
Dr. Robert Rex Dietz, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 2900 12th Ave N, Suite 210w, Billings, MT 59101
Phone: 406-237-5862    Fax: 406-238-6068
Tara S Bowman Seitz, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 2800 10th Ave N, Billings, MT 59101
Phone: 406-238-2500    
John M. Schallenkamp, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 801 N 29th St, Billings, MT 59101
Phone: 406-238-2500    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.